サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1666741

非がん性皮膚疾患治療薬の世界市場 2025～2029年

Global Non-cancerous Skin Diseases Therapeutics Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 222 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
非がん性皮膚疾患治療薬の世界市場 2025～2029年
出版日: 2025年02月26日
発行: TechNavio
ページ情報: 英文 222 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

非がん性皮膚疾患治療薬市場は、2024～2029年にかけて314億6,490万米ドル、予測期間中のCAGRは11.1％で成長すると予測されています。

当レポートでは、非がん性皮膚疾患治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、皮膚疾患の高い有病率、市場情勢における強力なパイプライン、個別化需要の高まりなどが牽引しています。

市場範囲
基準年 2025年
終了年 2029年
予測期間 2025～2029年
成長モメンタム 加速
前年比2025年 9.5%
CAGR 11.1%
増分額 314億6,490万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、マイクロバイオームと皮膚バリアへの注目の高まりが、今後数年間の非がん性皮膚疾患治療薬市場の成長を促進する主要な理由の1つであると指摘しています。また、皮膚疾患の誤診やヘルスケア支出の増加は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio別分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024年
  • 市場展望 2024～2029年

第5章 市場規模実績

  • 非がん性皮膚疾患治療薬の世界市場 2019～2023年
  • 治療領域別セグメント分析 2019～2023年
  • 投与経路別セグメント分析 2019～2023年
  • エンドユーザー別セグメント分析 2019～2023年
  • 地域別セグメント分析 2019～2023年
  • 国別セグメント分析 2019～2023年

第6章 定性分析

  • AIの影響：非がん性皮膚疾患治療薬の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：治療領域別

  • 市場セグメント
  • 比較：治療領域別
  • 乾癬：市場規模と予測 2024～2029年
  • 湿疹：市場規模と予測 2024～2029年
  • 尋常性ざ瘡：市場規模と予測 2024～2029年
  • その他：市場規模と予測 2024～2029年
  • 市場機会：治療領域別

第9章 市場セグメンテーション：投与経路別

  • 市場セグメント
  • 比較：投与経路別
  • 注射：市場規模と予測 2024～2029年
  • 経口：市場規模と予測 2024～2029年
  • 局所：市場規模と予測 2024～2029年
  • 市場機会：投与経路別

第10章 市場セグメンテーション：エンドユーザー別

  • 市場セグメント
  • 比較：エンドユーザー別
  • 病院：市場規模と予測 2024～2029年
  • 皮膚科クリニック：市場規模と予測 2024～2029年
  • ホームケア：市場規模と予測 2024～2029年
  • 市場機会：エンドユーザー別

第11章 顧客情勢

  • 顧客情勢の概要

第12章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024～2029年
  • 欧州：市場規模と予測 2024～2029年
  • アジア：市場規模と予測 2024～2029年
  • 世界のその他の地域：市場規模と予測 2024～2029年
  • 米国：市場規模と予測 2024～2029年
  • ドイツ：市場規模と予測 2024～2029年
  • フランス：市場規模と予測 2024～2029年
  • カナダ：市場規模と予測 2024～2029年
  • 日本：市場規模と予測 2024～2029年
  • インド：市場規模と予測 2024～2029年
  • 英国：市場規模と予測 2024～2029年
  • 中国：市場規模と予測 2024～2029年
  • 韓国：市場規模と予測 2024～2029年
  • 南アフリカ：市場規模と予測 2024～2029年
  • 市場機会：地域情勢別

第13章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第14章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第15章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Galderma SA
  • GlaxoSmithKline Plc
  • LEO Pharma AS
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.

第16章 付録

目次
Product Code: IRTNTR40772

The non-cancerous skin diseases therapeutics market is forecasted to grow by USD 31464.9 million during 2024-2029, accelerating at a CAGR of 11.1% during the forecast period. The report on the non-cancerous skin diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of skin diseases, strong pipeline landscape in non-cancerous skin diseases therapeutics, and growing demand for personalized non-cancerous skin diseases therapeutics.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20259.5%
CAGR11.1%
Incremental Value$31464.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's non-cancerous skin diseases therapeutics market is segmented as below:

By Therapy Area

    • Psoriasis
    • Eczema
    • Acne vulgaris
    • Others

By Route Of Administration

    • Injectable
    • Oral
    • Topical

By End-user

    • Hospitals
    • Dermatology Clinics
    • Homecare

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increased focus on microbiome and skin barrier as one of the prime reasons driving the non-cancerous skin diseases therapeutics market growth during the next few years. Also, misdiagnosis of skin diseases and increasing healthcare expenditure will lead to sizable demand in the market.

The report on the non-cancerous skin diseases therapeutics market covers the following areas:

    • Non-Cancerous Skin Diseases Therapeutics Market sizing
    • Non-Cancerous Skin Diseases Therapeutics Market forecast
    • Non-Cancerous Skin Diseases Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-cancerous skin diseases therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Galderma SA, GlaxoSmithKline PLC, Incyte Corp., LEO Pharma AS, Merck KGaA, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., UCB SA, Viatris Inc., and XBiotech Inc.. Also, the non-cancerous skin diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Therapy Area
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Non-Cancerous Skin Diseases Therapeutics Market 2019 - 2023
    • Historic Market Size - Data Table on Global Non-Cancerous Skin Diseases Therapeutics Market 2019 - 2023 ($ million)
  • 5.2 Therapy Area segment analysis 2019 - 2023
    • Historic Market Size - Therapy Area Segment 2019 - 2023 ($ million)
  • 5.3 Route of Administration segment analysis 2019 - 2023
    • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • 5.4 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI in global non-cancerous skin diseases therapeutics market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Therapy Area

  • 8.1 Market segments
    • Chart on Therapy Area - Market share 2024-2029 (%)
    • Data Table on Therapy Area - Market share 2024-2029 (%)
  • 8.2 Comparison by Therapy Area
    • Chart on Comparison by Therapy Area
    • Data Table on Comparison by Therapy Area
  • 8.3 Psoriasis - Market size and forecast 2024-2029
    • Chart on Psoriasis - Market size and forecast 2024-2029 ($ million)
    • Data Table on Psoriasis - Market size and forecast 2024-2029 ($ million)
    • Chart on Psoriasis - Year-over-year growth 2024-2029 (%)
    • Data Table on Psoriasis - Year-over-year growth 2024-2029 (%)
  • 8.4 Eczema - Market size and forecast 2024-2029
    • Chart on Eczema - Market size and forecast 2024-2029 ($ million)
    • Data Table on Eczema - Market size and forecast 2024-2029 ($ million)
    • Chart on Eczema - Year-over-year growth 2024-2029 (%)
    • Data Table on Eczema - Year-over-year growth 2024-2029 (%)
  • 8.5 Acne vulgaris - Market size and forecast 2024-2029
    • Chart on Acne vulgaris - Market size and forecast 2024-2029 ($ million)
    • Data Table on Acne vulgaris - Market size and forecast 2024-2029 ($ million)
    • Chart on Acne vulgaris - Year-over-year growth 2024-2029 (%)
    • Data Table on Acne vulgaris - Year-over-year growth 2024-2029 (%)
  • 8.6 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.7 Market opportunity by Therapy Area
    • Market opportunity by Therapy Area ($ million)
    • Data Table on Market opportunity by Therapy Area ($ million)

9 Market Segmentation by Route of Administration

  • 9.1 Market segments
    • Chart on Route of Administration - Market share 2024-2029 (%)
    • Data Table on Route of Administration - Market share 2024-2029 (%)
  • 9.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 9.3 Injectable - Market size and forecast 2024-2029
    • Chart on Injectable - Market size and forecast 2024-2029 ($ million)
    • Data Table on Injectable - Market size and forecast 2024-2029 ($ million)
    • Chart on Injectable - Year-over-year growth 2024-2029 (%)
    • Data Table on Injectable - Year-over-year growth 2024-2029 (%)
  • 9.4 Oral - Market size and forecast 2024-2029
    • Chart on Oral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • 9.5 Topical - Market size and forecast 2024-2029
    • Chart on Topical - Market size and forecast 2024-2029 ($ million)
    • Data Table on Topical - Market size and forecast 2024-2029 ($ million)
    • Chart on Topical - Year-over-year growth 2024-2029 (%)
    • Data Table on Topical - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by End-user

  • 10.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 10.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 10.3 Hospitals - Market size and forecast 2024-2029
    • Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospitals - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
  • 10.4 Dermatology clinics - Market size and forecast 2024-2029
    • Chart on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
    • Data Table on Dermatology clinics - Market size and forecast 2024-2029 ($ million)
    • Chart on Dermatology clinics - Year-over-year growth 2024-2029 (%)
    • Data Table on Dermatology clinics - Year-over-year growth 2024-2029 (%)
  • 10.5 Homecare - Market size and forecast 2024-2029
    • Chart on Homecare - Market size and forecast 2024-2029 ($ million)
    • Data Table on Homecare - Market size and forecast 2024-2029 ($ million)
    • Chart on Homecare - Year-over-year growth 2024-2029 (%)
    • Data Table on Homecare - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.9 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.10 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.11 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.12 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.13 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.14 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.15 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.16 South Africa - Market size and forecast 2024-2029
    • Chart on South Africa - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Africa - Market size and forecast 2024-2029 ($ million)
    • Chart on South Africa - Year-over-year growth 2024-2029 (%)
    • Data Table on South Africa - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 15.5 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
    • SWOT
  • 15.6 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 15.7 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
    • SWOT
  • 15.8 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
    • SWOT
  • 15.9 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 15.10 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.11 Galderma SA
    • Galderma SA - Overview
    • Galderma SA - Product / Service
    • Galderma SA - Key offerings
    • SWOT
  • 15.12 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 15.13 LEO Pharma AS
    • LEO Pharma AS - Overview
    • LEO Pharma AS - Product / Service
    • LEO Pharma AS - Key offerings
    • SWOT
  • 15.14 Merck KGaA
    • Merck KGaA - Overview
    • Merck KGaA - Business segments
    • Merck KGaA - Key news
    • Merck KGaA - Key offerings
    • Merck KGaA - Segment focus
    • SWOT
  • 15.15 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 15.16 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.17 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 15.18 Sun Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd. - Overview
    • Sun Pharmaceutical Industries Ltd. - Product / Service
    • Sun Pharmaceutical Industries Ltd. - Key news
    • Sun Pharmaceutical Industries Ltd. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations